StockData

BGM Group Ltd. (BGM) stock

BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jul 21, 2026Score 9/30
$8.13+0.00 (0.00%)

Close on Nov 18, 2026Market cap $3.26BP/E –Yield –

BGM operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$12.58M. The highest annual figure on record is $6.18M in fiscal 2019.

Annual operating income

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$12.58M–
FY2024Sep 30, 2024-$563.77K–
FY2023Sep 30, 2023-$2.61M-224.2%
FY2022Sep 30, 2022$2.10M-12.0%
FY2021Sep 30, 2021$2.39M-50.4%
FY2020Sep 30, 2020$4.81M-22.1%
FY2019Sep 30, 2019$6.18M+3.5%
FY2018Sep 30, 2018$5.97M–

More BGM figures

See a number that looks wrong?